| Medication reconciliation at admission and discharge: an analysis of prevalence and associated risk factors S Belda‐Rustarazo, J Cantero‐Hinojosa, A Salmeron‐Garcia, ... International journal of clinical practice 69 (11), 1268-1274, 2015 | 111 | 2015 |
| The innovative activity of foreign subsidiaries in the Spanish Innovation System: An evaluation of their impact from a sectoral taxonomy approach J Molero, A Garcia Technovation 28 (11), 739-757, 2008 | 103 | 2008 |
| Effects of the COVID-19 lockdown on urban light emissions: ground and satellite comparison M Bustamante-Calabria, A Sánchez de Miguel, S Martín-Ruiz, JL Ortiz, ... Remote Sensing 13 (2), 258, 2021 | 57 | 2021 |
| Determination of tramadol, metamizole, ropivacaine, and bupivacaine in analgesic mixture samples by HPLC with DAD detection A Salmerón-García, N Navas, A Martin, E Roman, J Cabeza, ... Journal of chromatographic science 47 (3), 231-237, 2009 | 41 | 2009 |
| The effects of light-accelerated degradation on the aggregation of marketed therapeutic monoclonal antibodies evaluated by size-exclusion chromatography with diode array detection J Hernández-Jiménez, A Salmerón-García, J Cabeza, C Vélez, ... Journal of pharmaceutical sciences 105 (4), 1405-1418, 2016 | 39 | 2016 |
| Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies I Suárez, A Salmerón-García, J Cabeza, LF Capitán-Vallvey, N Navas Journal of Chromatography B 1032, 155-164, 2016 | 37 | 2016 |
| Quantification of an intact monoclonal antibody, rituximab, by (RP) HPLC/DAD in compliance with ICH guidelines N Navas, A Herrera, A Martínez-Ortega, A Salmerón-García, J Cabeza, ... Analytical and bioanalytical chemistry 405, 9351-9363, 2013 | 37 | 2013 |
| Detoxification of aqueous solutions of the pesticide “Sevnol” by solar photocatalysis A Garcia, AM Amat, A Arques, R Sanchís, W Gernjak, MI Maldonado, ... Environmental Chemistry Letters 3 (4), 169-172, 2006 | 34 | 2006 |
| Medication reconciliation at admission to surgical departments L González‐García, A Salmerón‐García, MA García‐Lirola, ... Journal of evaluation in clinical practice 22 (1), 20-25, 2016 | 33 | 2016 |
| Study and ICH validation of a reverse-phase liquid chromatographic method for the quantification of the intact monoclonal antibody cetuximab A Martínez-Ortega, A Herrera, A Salmerón-García, J Cabeza, ... Journal of Pharmaceutical Analysis 6 (2), 117-124, 2016 | 31 | 2016 |
| Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term stability tests by analyzing size exclusion liquid chromatographic profiles J Hernández-Jiménez, A Martínez-Ortega, A Salmerón-García, J Cabeza, ... International journal of biological macromolecules 118, 511-524, 2018 | 30 | 2018 |
| Topical endotracheal mitomycin C as a complementary treatment for endoscopic treatment of recurrent laryngotracheal stenosis SC de Miguel, JC Barrera, MG Medina, LFCG de Cádiz, ... Farmacia Hospitalaria (English Edition) 35 (1), 32-35, 2011 | 28* | 2011 |
| ¿ Qué opinan los alumnos universitarios sobre las nuevas metodologías activas de enseñanza MJ Caurcel, A García, A Rodríguez, A Romero Revista de curriculum y formación del profesorado 13 (1), 305-309, 2009 | 27 | 2009 |
| Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum β-lactamase-producing Escherichia coli in Granada, Spain A Sorlozano, J Gutierrez, A Salmeron, JD Luna, F Martinez-Checa, ... International journal of antimicrobial agents 28 (6), 532-536, 2006 | 26 | 2006 |
| Validated reverse phase HPLC diode array method for the quantification of intact bevacizumab, infliximab and trastuzumab for long-term stability study A Martínez-Ortega, A Herrera, A Salmerón-García, J Cabeza, ... International journal of biological macromolecules 116, 993-1003, 2018 | 25 | 2018 |
| Close range photogrammetry and enhanced recording of Palaeolithic rock art JL Lerma, V Villaverde, A García, J Cardona Iaprs 36 (5), 147-154, 2006 | 25 | 2006 |
| Detection of adverse drug reactions through the minimum basic data set A Salmerón-García, J Cabeza Barrera, MJ Vergara Pavón, ... Pharmacy world & science 32, 322-328, 2010 | 20 | 2010 |
| Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation J Hermosilla, R Pérez-Robles, A Salmerón-García, S Casares, J Cabeza, ... Scientific Reports 10 (1), 2675, 2020 | 19 | 2020 |
| Comparative stability studies of different infliximab and biosimilar CT-P13 clinical solutions by combined use of physicochemical analytical techniques and enzyme-linked … J Hermosilla, R Sánchez-Martín, R Pérez-Robles, A Salmerón-García, ... BioDrugs 33, 193-205, 2019 | 19 | 2019 |
| Integración educativa o educación inclusiva,¿ qué conviene a México? Cátedra CUMEX de Psicología I García, A García, O Cruz A. García y O. Cruz (2015). Los retos de la psicología en la sociedad …, 2015 | 17 | 2015 |
JOSE GUTIERREZ-FERNANDEZ (http...Full Professor of Microbiology / Microbiologist. Granada University "Hospital Virgen de las Nieves"Dirección de correo verificada de ugr.es
